Theodora Tzanavari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Theodora Tzanavari has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Katia Karalis
3 shared publications- Aimilia Varela
Cardiovascular Research Laboratory, Center for Clinical Research, Experimental Surgery and Translational Research, Biomedical Research Foundation, Academy of Athens, GR 11527 Athens, Greece
2 shared publications - Constantinos Pantos
Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
2 shared publications Dennis Cokkinos
2 shared publications- Katia P. Karalis
Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece; Endocrine Division, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA
2 shared publications Stamatis Theocharis
First Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
2 shared publications
Latest Publications
- 1 October 2016
- Published by Elsevier in Metabolism
- Vol. 65 (10) , 1447-1458
Metformin protects against infection-induced myocardial dysfunction
- 1 October 2016
- Published by Elsevier in Metabolism
- Vol. 65 (10) , 1447-1458
Metformin protects against infection-induced myocardial dysfunction
- 22 September 2014
- Published by Springer Nature
- p. 239-251
Stress Proteins and the Adaptive Response of the Heart
- 22 September 2014
- Published by Springer Nature
- p. 239-251
Stress Proteins and the Adaptive Response of the Heart
- 1 April 2013
- Published by Bioscientifica in Endocrine Abstracts
The role of costimulatory molecules B7.1 and B7.2 in obesity-related adipose tissue inflammation and liver steatosis
Introduction: Macrophages and lymphocytes are considered as major players in adipose tissue (AT) inflammation and liver steatosis, contributing to metabolic dysregulation during obesity. The costimulatory molecules B7.1 and B7.2 are important regulators of T-cell activation and inflammatory reactions, however, their contribution in obesity-related AT and liver low-grade inflammation is poorly characterized. Methods: Mice sufficient or deficient in B7.1 and B7.2 (double knockouts, Dko) were fed a low or high-fat diet (HFD) for 18 weeks. Body weight was measured weekly and metabolic functions were assessed by measuring blood glucose, cholesterol, triglycerides, insulin, leptin, adiponectin and performing glucose and insulin tolerance tests. Subcutaneous and gonadal AT were excised and the stromal vascular fraction (SVF) was analyzed by FACS. Liver steatosis was evaluated by measuring intratissular triglycerides and confirmed by H&E and Oil-Red stainings. Liver non-parenchymal cells were isolated and analysed by FACS. The levels of inflammation, thermogenesis and fat deposition genes were measured by qPCR in white and brown adipose tissue and liver respectively. Results: B7.1 and B7.2 expression was upregulated in gonadal AT and SVF upon HFD. Dko mice displayed higher glucose, cholesterol and leptin levels and worse GTT when fed a HFD compared to the B7.1/B7.2 sufficient mice. This was accompanied by downregulation of Tregs, CD4 and CD8 lymphocytes and a parallel upregulation of proinflammatory M1 macrophages (defined as F4/80+CD11b+CD11c+ or F4/80+CD11c+CD206-cells) in both subcutaneous and gonadal AT. Dko mice showed also increased liver steatosis, linked with increased levels of inflammatory M1-like macrophages and reduced levels of Tregs in the liver. In accordance, Dko mice had higher levels of inflammation and fat accumulation genes in AT and liver respectively and lower levels of UCP-1 in the brown AT. Conclusion: The B7.1-B7.2 signalling pathways are significant regulators of the obesity-related adipose tissue inflammation and liver steatosis pathophysiology.
- 1 April 2013
- Published by Bioscientifica in Endocrine Abstracts
The role of costimulatory molecules B7.1 and B7.2 in obesity-related adipose tissue inflammation and liver steatosis
Introduction: Macrophages and lymphocytes are considered as major players in adipose tissue (AT) inflammation and liver steatosis, contributing to metabolic dysregulation during obesity. The costimulatory molecules B7.1 and B7.2 are important regulators of T-cell activation and inflammatory reactions, however, their contribution in obesity-related AT and liver low-grade inflammation is poorly characterized. Methods: Mice sufficient or deficient in B7.1 and B7.2 (double knockouts, Dko) were fed a low or high-fat diet (HFD) for 18 weeks. Body weight was measured weekly and metabolic functions were assessed by measuring blood glucose, cholesterol, triglycerides, insulin, leptin, adiponectin and performing glucose and insulin tolerance tests. Subcutaneous and gonadal AT were excised and the stromal vascular fraction (SVF) was analyzed by FACS. Liver steatosis was evaluated by measuring intratissular triglycerides and confirmed by H&E and Oil-Red stainings. Liver non-parenchymal cells were isolated and analysed by FACS. The levels of inflammation, thermogenesis and fat deposition genes were measured by qPCR in white and brown adipose tissue and liver respectively. Results: B7.1 and B7.2 expression was upregulated in gonadal AT and SVF upon HFD. Dko mice displayed higher glucose, cholesterol and leptin levels and worse GTT when fed a HFD compared to the B7.1/B7.2 sufficient mice. This was accompanied by downregulation of Tregs, CD4 and CD8 lymphocytes and a parallel upregulation of proinflammatory M1 macrophages (defined as F4/80+CD11b+CD11c+ or F4/80+CD11c+CD206-cells) in both subcutaneous and gonadal AT. Dko mice showed also increased liver steatosis, linked with increased levels of inflammatory M1-like macrophages and reduced levels of Tregs in the liver. In accordance, Dko mice had higher levels of inflammation and fat accumulation genes in AT and liver respectively and lower levels of UCP-1 in the brown AT. Conclusion: The B7.1-B7.2 signalling pathways are significant regulators of the obesity-related adipose tissue inflammation and liver steatosis pathophysiology.
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 93
292 CRH regulates cardiac function in normal and inflammatory states
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 93
292 CRH regulates cardiac function in normal and inflammatory states
- 1 June 2011
- Published by The Endocrine Society
- p. P1-579
CRH Regulates Cardiac Function in Normal Conditions and Infection
Article published by the Endocrine Society Article published by the Endocrine Society
- 1 June 2011
- Published by The Endocrine Society
- p. P1-579
CRH Regulates Cardiac Function in Normal Conditions and Infection
Article published by the Endocrine Society Article published by the Endocrine Society